1.37

0.00% 0.00

Enveric Biosciences Inc (ENVB)

Panoramica Notizia Cronologia dei prezzi Financials Forum Previsione Frazionamento azionario Storia dei dividendi

Precedente Chiudi:

$1.37

Aprire:

$1.41

Volume 24 ore:

22,170

Relative Volume:

0.13

Capitalizzazione di mercato:

$6.13M

Reddito:

Utile/perdita netta:

$-8.22M

Rapporto P/E:

-0.0501

EPS:

-27.3467

Flusso di cassa netto:

$-8.01M

1 W Prestazione:

-4.20%

1M Prestazione:

+3.01%

6M Prestazione:

-41.70%

1 anno Prestazione:

-90.94%

Intervallo 1D:

$1.34

$1.41

Intervallo di 1 settimana:

$1.1701

$1.52

Portata 52W:

$1.1701

$15.12

Enveric Biosciences Inc Stock (ENVB) Company Profile

Nome

Enveric Biosciences Inc

Settore

Healthcare (1080)

Industria

Biotechnology (605)

Telefono

(617) 444-8400

Indirizzo

245 FIRST STREET RIVERVIEW II 18TH FLOOR, CAMBRIDGE

Dipendente

Cinguettio

Prossima data di guadagno

2026-08-13

Ultimi documenti SEC

ENVB's Discussions on Twitter

Compare ENVB vs VRTX, REGN, ARGX, MRNA, RVMD

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ENVB Enveric Biosciences Inc	1.37	6.22M	0	-8.22M	-8.01M	-27.35
VRTX Vertex Pharmaceuticals Inc	541.69	136.93B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	794.19	85.11B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,023.21	64.95B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	137.99	53.23B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	207.88	45.38B	742.00K	-1.37B	-1.07B	-7.0731

Enveric Biosciences Inc Borsa (ENVB) Ultime notizie

Aug 20, 2026

ARMISTICE CAPITAL, LLC Acquires Stake in Enveric Biosciences Inc (ENVB) - GuruFocus

Aug 20, 2026

Aug 19, 2026

Enveric (ENVB) Snapshot: Slides 0.74% to $1.34 in the Latest Reading; Technical View: Support at $1.27 and Resistance at $1.41 Frame the Range in Latest TradingFundamental Weighted - vinanet.vn

Aug 19, 2026

Aug 18, 2026

Enveric (ENVB) Daily Review: Moves 8.78% Lower to $1.35 for the Current Session; Price-Level Context: the Supplied Trading Band Runs From $1.28 to $1.42 in Latest TradingVanna Flow - vinanet.vn

Aug 18, 2026

Aug 17, 2026

Enveric Biosciences (ENVB) Q2 Results Highlight Challenges Amid Low Valuation Signals - GuruFocus

Aug 17, 2026

Aug 16, 2026

Enveric Biosciences Reports Financial Results and Provides Corporate Update for Second Quarter 2026 - BioSpace

Aug 16, 2026

Aug 14, 2026

Enveric Biosciences Announces Withdrawal Of Petition Against Its Patent — ENVB Stock Rises - Stocktwits

Aug 14, 2026

Form 8K Enveric Biosciences Inc For: 14 August By Investing.com - Investing.com Nigeria

Aug 14, 2026

Enveric Biosciences reports $3.0M net loss, $8.3M cash on hand for Q2 2026 - TradingView

Aug 14, 2026

Enveric Biosciences (ENVB) posts H1 2026 loss but raises $8.3M cash - Stock Titan

Aug 14, 2026

Enveric Biosciences Posts $3.0 Million Second-Quarter Net Loss - Quiver Quantitative

Aug 14, 2026

Enveric Biosciences (NASDAQ: ENVB) deepens Q2 loss while pushing EB-003 toward trials - Stock Titan

Aug 14, 2026

Enveric Biosciences (ENVB) holders Lind entities report 1.3–1.4% warrant-based stake - Stock Titan

Aug 14, 2026

Armistice Capital (ENVB) discloses 405,092-share position in Enveric Biosciences - Stock Titan

Aug 14, 2026

Aug 13, 2026

Enveric Biosciences (ENVB) investors disclose 2.93% stake via 111,145-share warrants - Stock Titan

Aug 13, 2026

Aug 11, 2026

FDA Fast-Tracks Psychedelic Research After Trump’s Executive Order — CMPS, HELP Stocks Gain - Stocktwits

Aug 11, 2026

Enveric Biosciences Adds Another Data Point to Its Case That EB-003 Won’t Get You High - microdose.buzz

Aug 11, 2026

Aug 08, 2026

ENVB Q4 2024 Earnings: Per-Share Loss of -57.6 Overshoots Consensus by 1,946%Management Guidance Update - Vinanet

Aug 08, 2026

Aug 07, 2026

Enveric Biosciences Inc (NASDAQ: ENVB) Share Price, ENVB Stock News, ENVB Share Price & Updates - Kalkine

Aug 07, 2026

Aug 05, 2026

Enveric Biosciences Says New Preclinical Data Confirms Non-Hallucinogenic Profile For Lead Psychiatric Ca - Benzinga

Aug 05, 2026

Enveric reports preclinical data on EB-003 drug candidate By Investing.com - Investing.com Canada

Aug 05, 2026

Enveric Biosciences Reports New Preclinical Data Supporting the Non-Hallucinogenic Profile of Lead Candidate EB-003 - Yahoo! Finance Canada

Aug 05, 2026

Aug 01, 2026

Enveric Biosciences (ENVB) Rallies 8.4% to $1.57 — Key Levels to WatchStock Analysis - dars.gov.et

Aug 01, 2026

Jul 28, 2026

Enveric Biosciences Welcomes Final FDA Guidance for Psychedelic Drug Development - Investing News Network

Jul 28, 2026

Jul 27, 2026